Clinical Trial Update: Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection [Phase 2]

View source ↗

Summary

Phase II randomized trial assessing safety and immunogenicity of MVA-BN Smallpox Vaccine in HIV-infected immunocompromised subjects; study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• MVA-BN Smallpox vaccine (Modified Vaccinia Ankara-Bavarian Nordic)

Snippet

Sponsor: Bavarian Nordic | Conditions: Smallpox | Phase 2 | Status: COMPLETED | Results posted: 2020-04-02